Science-Based Thinking Promises Global Progress On Biosimilars

Samsung Bioepis’ Gillian Woollett Discusses Latest Regulatory Developments

 
• By David Wallace
  
Injectable vial biosimilar close-up
Progress for biosimilars is inevitable, assuming a science-based approach, Woollett believes • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products